Project Grant R01HL175636
Award Date
9/1/24
Completion Date
7/31/29
Dollars Obligated
$627K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Miami, FL 33199, USA
Similar Awards
This federal Project Grant award for $648,073 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support a study titled "The ADHINCRA Study: Addressing Hypertension Care in Africa." The study aims to implement and evaluate multilevel interventions, including team-based care and telehealth with home blood pressure monitoring, to improve hypertension control in Ghana and Nigeria. The research will be...
This $1,742,902 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a research study to investigate racial/ethnic disparities in cardiovascular disease (CVD) risk factors and subclinical abnormalities among young adults with type 1 diabetes. The study will enroll 1,000 participants, including 300 Hispanic or non-Hispanic Black young adults, to rigorously assess CVD-related structural and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports a late-stage implementation strategy to evaluate the use of a "heart failure polypill" in India. The $498,129.23 award, granted on December 9, 2024, aims to simplify the management of heart failure with reduced ejection fraction (HFrEF) by shifting from multi-drug therapy to a single polypill containing a beta-blocker,...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), will provide $198,936 to New York University (NYU) School of Medicine to investigate the impact of restrictive drug coverage policies on heart failure care. The key objectives are to: 1) quantify the effects of restrictive drug coverage policies on provider prescribing, patient adherence, and clinical outcomes for...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,820 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to New York University School of Medicine to leverage community engagement to sustain integrated care models for people living with HIV/AIDS (PLWH) and non-communicable diseases (NCDs) in Nigeria. The key objectives are to: 1) identify barriers and facilitators to developing a community-clinical linkage model for PLWH with hypertension, 2) co-develop a...
This federal Project Grant award of $1,405,336.00 was made on September 1, 2024 by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports research at Florida International University (FIU) focused on understanding the pathophysiological mechanisms of HIV-associated chronic obstructive pulmonary disease (COPD). The key research objectives are to: 1) Identify how HIV Tat protein and cigarette smoke exposure alter the...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,321,108 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to New York University School of Medicine to conduct transdisciplinary implementation research on a strategy called PT4A. PT4A integrates peer-based medication delivery, peer coaching, and health information technology to improve medication adherence and reduce blood pressure among patients with uncontrolled hypertension in Western Kenya. The study aims to...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $116,748 to Washington University in St. Louis to conduct advanced implementation research and enhance the PI's mentorship capabilities in global cardiovascular patient-oriented research. The key research activities include: 1) Analyzing the impact of team-based care on hypertension control rates in Nigeria, 2) Defining patient retention patterns in hypertension...
This $248,998 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a comprehensive research plan and career development activities for the awardee, Dr. Hughes. The project aims to investigate the role of autophagy, a cellular process, in contributing to microvascular dysfunction associated with type 2 diabetes mellitus (T2DM). Key products and services to be delivered through this 3-year...
This federal Project Grant award with ID R61HL172269, totaling $724,064.00, was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will fund the development and evaluation of a multi-level, integrated intervention called "HTN-Urban" to improve hypertension control among adults living in urban Vietnam. Key components of the intervention include a storytelling program, home blood pressure...